Perequietil

Perequietil Brand names, Perequietil Analogs

Perequietil Brand Names Mixture

No information avaliable

Perequietil Chemical_Formula

C₂₀H₂₃NS

Perequietil RX_link

No information avaliable

Perequietil fda sheet

Perequietil msds (material safety sheet)

Perequietil Synthesis Reference

No information avaliable

Perequietil Molecular Weight

309.469 g/mol

Perequietil Melting Point

< 25 ^oC

Perequietil H₂O Solubility

Soluble as HCl salt

Perequietil State

Liquid

Perequietil LogP

5.7

Perequietil Dosage Forms

Tablets (oral, 1 mg)

Perequietil Indication

Used for the symptomatic treatment of parkinsonism.

Perequietil Pharmacology

Metixene is a tertiary antimuscarinic with actions similar to those of atropine; it also has antihistaminic and direct antispasmodic properties. It is used for the symptomatic treatment of parkinsonism, including the alleviation of the extrapyramidal syndrome induced by other drugs such as phenothiazines, but, like other antimuscarinics, it is of no value against tardive dyskinesias. Metixene has been discontinued.

Perequietil Absorption

Absorbed in the gastrointestinal tract following oral administration, however the extent of absorption is not known.

Perequietil side effects and Toxicity

Signs of overdose include dilated and sluggish pupils, warm, dry skin, facial flushing, decreased secretions of the mouth, pharynx, nose, and bronchi, foul-smelling breath, elevated temperature, tachycardia, cardiac arrhythmias, decreased bowel sounds, urinary retention, delirium, disorientation, anxiety, hallucinations, illusions, confusion, incoherence, agitation, hyperactivity, ataxia, loss of memory, paranoia, combativeness, and seizures.

Perequietil Patient Information

Perequietil Organisms Affected

Humans and other mammals